Cullinan Therapeutics, Inc.CGEMNASDAQ
Loading
Cash & Equivalents Over TimeStable
Percentile Rank57
3Y CAGR-17.3%
5Y CAGR-12.1%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-17.3%/yr
vs +46.6%/yr prior
5Y CAGR
-12.1%/yr
Recent deceleration
Acceleration
-63.9pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $88.33M | +6.4% |
| 2024 | $83.00M | -15.7% |
| 2023 | $98.43M | -37.0% |
| 2022 | $156.15M | +161.2% |
| 2021 | $59.77M | -64.5% |
| 2020 | $168.20M | +165.9% |
| 2019 | $63.25M | +87.0% |
| 2018 | $33.83M | - |